8.63
+0.23(+2.74%)
Currency In USD
| Previous Close | 8.4 |
| Open | 8.38 |
| Day High | 8.65 |
| Day Low | 8.36 |
| 52-Week High | 31.79 |
| 52-Week Low | 6.32 |
| Volume | 751,684 |
| Average Volume | 963,771 |
| Market Cap | 354.84M |
| PE | -9.81 |
| EPS | -0.88 |
| Moving Average 50 Days | 10.29 |
| Moving Average 200 Days | 10.45 |
| Change | 0.23 |
If you invested $1000 in RxSight, Inc. (RXST) since IPO date, it would be worth $539.38 as of February 21, 2026 at a share price of $8.63. Whereas If you bought $1000 worth of RxSight, Inc. (RXST) shares 3 years ago, it would be worth $627.18 as of February 21, 2026 at a share price of $8.63.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
GlobeNewswire Inc.
Feb 11, 2026 9:10 PM GMT
ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the fourth qu
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
GlobeNewswire Inc.
Jan 11, 2026 2:30 PM GMT
ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preli
RxSight, Inc. Announces Chief Financial Officer Transition
GlobeNewswire Inc.
Dec 22, 2025 10:15 PM GMT
ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Compan